These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27570076)

  • 41. Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo.
    Beam M; Silva MC; Morimoto RI
    J Biol Chem; 2012 Jul; 287(31):26136-45. PubMed ID: 22669943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Astrocytic expression of the chaperone DNAJB6 results in non-cell autonomous protection in Huntington's disease.
    Bason M; Meister-Broekema M; Alberts N; Dijkers P; Bergink S; Sibon OCM; Kampinga HH
    Neurobiol Dis; 2019 Apr; 124():108-117. PubMed ID: 30408590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
    Chen M; Wolynes PG
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.
    Morley JF; Brignull HR; Weyers JJ; Morimoto RI
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10417-22. PubMed ID: 12122205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prefoldin protects neuronal cells from polyglutamine toxicity by preventing aggregation formation.
    Tashiro E; Zako T; Muto H; Itoo Y; Sörgjerd K; Terada N; Abe A; Miyazawa M; Kitamura A; Kitaura H; Kubota H; Maeda M; Momoi T; Iguchi-Ariga SM; Kinjo M; Ariga H
    J Biol Chem; 2013 Jul; 288(27):19958-72. PubMed ID: 23720755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates.
    Hazeki N; Tukamoto T; Goto J; Kanazawa I
    Biochem Biophys Res Commun; 2000 Oct; 277(2):386-93. PubMed ID: 11032734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides.
    Gillis J; Schipper-Krom S; Juenemann K; Gruber A; Coolen S; van den Nieuwendijk R; van Veen H; Overkleeft H; Goedhart J; Kampinga HH; Reits EA
    J Biol Chem; 2013 Jun; 288(24):17225-37. PubMed ID: 23612975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease.
    Guzhova IV; Lazarev VF; Kaznacheeva AV; Ippolitova MV; Muronetz VI; Kinev AV; Margulis BA
    Hum Mol Genet; 2011 Oct; 20(20):3953-63. PubMed ID: 21775503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
    Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA
    Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In Situ Architecture and Cellular Interactions of PolyQ Inclusions.
    Bäuerlein FJB; Saha I; Mishra A; Kalemanov M; Martínez-Sánchez A; Klein R; Dudanova I; Hipp MS; Hartl FU; Baumeister W; Fernández-Busnadiego R
    Cell; 2017 Sep; 171(1):179-187.e10. PubMed ID: 28890085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toll-interacting protein pathway: degradation of an ubiquitin-binding protein.
    Shimizu M; Oguro-Ando A; Ohoto-Fujita E; Atomi Y
    Methods Enzymol; 2014; 534():323-30. PubMed ID: 24359962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington's disease model system.
    Xi W; Wang X; Laue TM; Denis CL
    Sci Rep; 2016 Oct; 6():34916. PubMed ID: 27721444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.
    Chai Y; Shao J; Miller VM; Williams A; Paulson HL
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9310-5. PubMed ID: 12084819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inefficient degradation of truncated polyglutamine proteins by the proteasome.
    Holmberg CI; Staniszewski KE; Mensah KN; Matouschek A; Morimoto RI
    EMBO J; 2004 Oct; 23(21):4307-18. PubMed ID: 15470501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
    Schipper-Krom S; Juenemann K; Jansen AH; Wiemhoefer A; van den Nieuwendijk R; Smith DL; Hink MA; Bates GP; Overkleeft H; Ovaa H; Reits E
    FEBS Lett; 2014 Jan; 588(1):151-9. PubMed ID: 24291262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polyglutamine domain proteins with expanded repeats bind neurofilament, altering the neurofilament network.
    Nagai Y; Onodera O; Strittmatter WJ; Burke JR
    Ann N Y Acad Sci; 1999; 893():192-202. PubMed ID: 10672238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
    Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
    Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A protein polymerization cascade mediates toxicity of non-pathological human huntingtin in yeast.
    Serpionov GV; Alexandrov AI; Antonenko YN; Ter-Avanesyan MD
    Sci Rep; 2015 Dec; 5():18407. PubMed ID: 26673834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The β-turn-supporting motif in the polyglutamine binding peptide QBP1 is essential for inhibiting huntingtin aggregation.
    Belwal VK; Datta D; Chaudhary N
    FEBS Lett; 2020 Sep; 594(17):2894-2903. PubMed ID: 32592593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular basis of Q-length selectivity for the MW1 antibody-huntingtin interaction.
    Bravo-Arredondo JM; Venkataraman R; Varkey J; Isas JM; Situ AJ; Xu H; Chen J; Ulmer TS; Langen R
    J Biol Chem; 2023 Apr; 299(4):104616. PubMed ID: 36931390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.